Neuroleptic malignant syndrome

Common Name(s)

Neuroleptic malignant syndrome

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Neuroleptic malignant syndrome" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Neuroleptic malignant syndrome" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Neuroleptic malignant syndrome" returned 146 free, full-text research articles on human participants. First 3 results:

Catatonic Symptoms Appearing before Autonomic Symptoms Help Distinguish Neuroleptic Malignant Syndrome from Malignant Catatonia.
 

Author(s): Takayuki Komatsu, Tomohisa Nomura, Hiroki Takami, So Sakamoto, Keiko Mizuno, Hajime Sekii, Kotaro Hatta, Manabu Sugita

Journal: Intern. Med.. ;55(19):2893-2897.

 

A 42-year-old Japanese woman with a 10-year history of schizophrenia was admitted due to a disturbance in consciousness that met the diagnostic criteria for both neuroleptic malignant syndrome (NMS) and malignant catatonia. Despite systemic supportive treatments, the catatonic symptoms ...

Last Updated: 11 Oct 2016

Go To URL
A Reversible Isolated Lesion in the Splenium of Corpus Callosum in a Patient with Probable Neuroleptic Malignant Syndrome -- Case Report.
 

Author(s): Chieh-Tsung Yeh, Chin-Hua Fu

Journal: Acta Neurol Taiwan. 2015 Sep;24(3)():87-91.

 

A reversible isolated lesion in the splenium of the corpus callosum (SCC) is rare. We present such a case in a young female patient with neuroleptic malignant syndrome (NMS) and elaborate on its proposed pathophysiology and the possible differential diagnoses.

Last Updated: 23 Jun 2016

Go To URL
Neuroleptic malignant syndrome in cycloserine-induced psychosis.
 

Author(s): Neena S Sawant, Natasha S Kate, Swaroop S Bhatankar, Prathamesh S Kulkarni

Journal: Indian J Pharmacol. ;47(3):328-9.

 

A 33-year-old multidrug-resistant tuberculosis female patient diagnosed as cycloserine-induced psychosis developed several neuroleptic side effects such as extrapyramidal reaction, neuroleptic malignant syndrome, and drug-induced parkinsonism while she was being treated with initially ...

Last Updated: 13 Jun 2015

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Neuroleptic malignant syndrome" returned 22 free, full-text review articles on human participants. First 3 results:

A Case Report of Catatonia and Neuroleptic Malignant Syndrome With Multiple Treatment Modalities: Short Communication and Literature Review.
 

Author(s): Yu-Jie Chiou, Yu Lee, Chin-Chuen Lin, Tiao-Lai Huang

Journal: Medicine (Baltimore). 2015 Oct;94(43):e1752.

 

We describe a case with complicated clinical presentations who was difficult to treat. We described the possible etiologies and differential diagnosis of neuroleptic malignant syndrome (NMS), catatonia, and infection, in details. This patient was also referred to neuro-intensive care ...

Last Updated: 30 Oct 2015

Go To URL
Neuroleptic Malignant Syndrome: A Review from a Clinically Oriented Perspective.
 

Author(s): Lurdes Tse, Alasdair M Barr, Vanessa Scarapicchia, Fidel Vila-Rodriguez

Journal: Curr Neuropharmacol. 2015 ;13(3):395-406.

 

Neuroleptic malignant syndrome (NMS) is a rare but potentially life-threatening side-effect that can occur in response to treatment with antipsychotic drugs. Symptoms commonly include hyperpyrexia, muscle rigidity, autonomic dysfunction and altered mental status. In the current review ...

Last Updated: 28 Sep 2015

Go To URL
Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis.
 

Author(s): Martino Belvederi Murri, Argentina Guaglianone, Michele Bugliani, Pietro Calcagno, Matteo Respino, Gianluca Serafini, Marco Innamorati, Maurizio Pompili, Mario Amore

Journal: Drugs R D. 2015 Mar;15(1):45-62.

 

Neuroleptic malignant syndrome (NMS) is a rare, severe, idiosyncratic adverse reaction to antipsychotics. Second-generation antipsychotics (SGAs) were originally assumed to be free from the risk of causing NMS, however several cases of NMS induced by SGAs (SGA-NMS) have been reported.

Last Updated: 16 Mar 2015

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Reducing Orthostatic Intolerance With Oral Rehydration in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients
 

Status: Recruiting

Condition Summary: Chronic Fatigue Syndrome; Myalgic Encephalomyelitis; Systemic Exertion Intolerance Disease (SEID); Postural Tachycardia Syndrome (POTS); Neurally Mediated Syncope (NMS)

 

Last Updated: 29 Jul 2016

Go to URL